| Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa AJ Kunz Coyne, A El Ghali, D Holger, N Rebold, MJ Rybak Infectious diseases and therapy 11 (2), 661-682, 2022 | 130 | 2022 |
| CYP2C19 and STAT6 variants influence the outcome of proton pump inhibitor therapy in pediatric eosinophilic esophagitis EB Mougey, A Williams, AJK Coyne, C Gutiérrez-Junquera, ... Journal of Pediatric Gastroenterology and Nutrition 69 (5), 581-587, 2019 | 33 | 2019 |
| Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro: Bacteriophage-Antibiotic Combination R Kebriaei, KL Lev, RM Shah, KC Stamper, DJ Holger, T Morrisette, ... Microbiology Spectrum 10 (2), e00411-22, 2022 | 23 | 2022 |
| Optimization of phage-antibiotic combinations against Staphylococcus aureus biofilms R Kebriaei, SM Lehman, RM Shah, KC Stamper, AJ Kunz Coyne, ... Microbiology Spectrum 11 (3), e04918-22, 2023 | 15 | 2023 |
| Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility AJK Coyne, K Stamper, R Kebriaei, DJ Holger, A El Ghali, T Morrisette, ... Antibiotics 11 (9), 1175, 2022 | 15 | 2022 |
| Influence of antimicrobial stewardship and molecular rapid diagnostic tests on antimicrobial prescribing for extended-spectrum beta-lactamase-and carbapenemase-producing … AJ Kunz Coyne, AM Casapao, C Isache, J Morales, YS McCarter, ... Microbiology Spectrum 9 (2), e00464-21, 2021 | 14 | 2021 |
| Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium K Lev, AJ Kunz Coyne, R Kebriaei, T Morrisette, K Stamper, DJ Holger, ... Antibiotics 11 (3), 392, 2022 | 11 | 2022 |
| Novel Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Necrotizing Pneumonia Complicated by Empyema: A Case Report DJ Holger, AJ Kunz Coyne, JJ Zhao, A Sandhu, H Salimnia, MJ Rybak Open forum infectious diseases 9 (4), ofac092, 2022 | 10 | 2022 |
| Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections A El‐Ghali, AJ Kunz Coyne, K Caniff, C Bleick, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43 (6 …, 2023 | 9 | 2023 |
| Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure N Rebold, AM Lagnf, S Alosaimy, DJ Holger, P Witucki, A Mannino, ... Microbiology Spectrum 11 (1), e02647-22, 2023 | 9 | 2023 |
| Effectiveness and safety of beta-lactam antibiotics with and without therapeutic drug monitoring in patients with pseudomonas aeruginosa pneumonia or bloodstream infection AJ Kunz Coyne, M Alshaer, AM Casapao, V Venugopalan, C Isache, ... Antimicrobial Agents and Chemotherapy 66 (10), e00646-22, 2022 | 8 | 2022 |
| Eravacycline, the first four years: Health outcomes and tolerability data for 19 hospitals in 5 US regions from 2018 to 2022 AJ Kunz Coyne, S Alosaimy, K Lucas, AM Lagnf, T Morrisette, KC Molina, ... Microbiology Spectrum 12 (1), e02351-23, 2024 | 7 | 2024 |
| Nephrotoxicity of vancomycin in combination with beta-lactam agents: ceftolozane-tazobactam vs piperacillin-tazobactam S Alosaimy, AM Lagnf, ALV Hobbs, M Mubarez, WD Kufel, T Morrisette, ... Clinical Infectious Diseases 76 (3), e1444-e1455, 2023 | 7 | 2023 |
| Phage-antibiotic cocktail rescues daptomycin and phage susceptibility against daptomycin-nonsusceptible Enterococcus faecium in a simulated endocardial vegetation ex vivo model AJ Kunz Coyne, K Stamper, A El Ghali, R Kebriaei, B Biswas, M Wilson, ... Microbiology Spectrum 11 (4), e00340-23, 2023 | 6 | 2023 |
| Impact of ceftolozane–tazobactam vs. best alternative therapy on clinical outcomes in patients with multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa … DJ Holger, NS Rebold, S Alosaimy, T Morrisette, A Lagnf, AC Belza, ... Infectious Diseases and Therapy 11 (5), 1965-1980, 2022 | 6 | 2022 |
| Phage cocktails with daptomycin and ampicillin eradicates biofilm-embedded multidrug-resistant Enterococcus faecium with preserved phage susceptibility. Antibiotics (Basel) 11 … AJ Kunz Coyne, K Stamper, R Kebriaei, DJ Holger, A El Ghali, ... | 6 | 2022 |
| High-dose cefepime vs carbapenems for bacteremia caused by Enterobacterales with moderate to high risk of clinically significant AmpC β-lactamase production AJ Kunz Coyne, A El Ghali, K Lucas, P Witucki, N Rebold, DJ Holger, ... Open Forum Infectious Diseases 10 (3), ofad034, 2023 | 5 | 2023 |
| Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistant Stenotrophomonas maltophilia AJ Kunz Coyne, S Herbin, K Caniff, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43 (8 …, 2023 | 3 | 2023 |
| Post‐graduate pharmacy fellowships: The current state of affairs AT Elmes, DJ Holger, K Cieslak, D Desai, AJ Kunz Coyne, V Patel, ... Journal of the American College of Clinical Pharmacy 6 (2), 145-153, 2023 | 3 | 2023 |
| Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models DJ Holger, A El Ghali, N Bhutani, KL Lev, K Stamper, R Kebriaei, ... Antimicrobial Agents and Chemotherapy 67 (11), e00578-23, 2023 | 2 | 2023 |
